LEXARIA BIOSCIENCE CORP. Lessee, Operating Lease, Liability, to be Paid, Year One
LEXARIA BIOSCIENCE CORP. (LEXX) had Lessee, Operating Lease, Liability, to be Paid, Year One of $38.64 thousand as of 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-07-13
- 2026-05-31: Lessee, Operating Lease, Liability, to be Paid, Year One $38.64K.
- 2026-02-28: Lessee, Operating Lease, Liability, to be Paid, Year One $18.67K.
- 2025-11-30: Lessee, Operating Lease, Liability, to be Paid, Year One $28.01K.
- 2025-08-31: Lessee, Operating Lease, Liability, to be Paid, Year One $38.64K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One | Lessee, Operating Lease, Liability, to be Paid, Year One as first filed |
|---|---|---|
| 2026-05-31 | $38.64K 10-Q · filed 2026-07-13 | |
| 2026-02-28 | $18.67K 10-Q · filed 2026-04-13 | |
| 2025-11-30 | $28.01K 10-Q · filed 2026-01-13 | |
| 2025-08-31 | $38.64K 10-K · filed 2025-11-28 | |
| 2025-05-31 | $37.34K 10-Q · filed 2025-07-14 | |
| 2025-02-28 | $37.34K 10-Q · filed 2025-04-14 | |
| 2024-11-30 | $0.00 10-Q · filed 2025-01-10 | |
| 2024-08-31 | $0.00 10-K · filed 2024-11-26 | |
| 2024-05-31 | $8.96K 10-Q · filed 2024-07-12 | |
| 2024-02-29 | $17.92K 10-Q · filed 2024-04-09 | |
| 2023-11-30 | $26.88K 10-Q · filed 2024-01-12 | |
| 2023-08-31 | $35.84K 10-K · filed 2023-11-20 | |
| 2023-03-31 | $35.84K 10-Q · filed 2023-07-14 | |
| 2023-02-28 | $7.47K 10-Q · filed 2023-04-14 | |
| 2022-11-30 | $33.61K 10-Q/A · filed 2023-01-18 | |
| 2022-05-31 | $44.81K 10-K · filed 2022-11-28 | $44.82K 10-Q · filed 2022-07-14 |
| 2021-05-31 | $10.99K 10-Q · filed 2021-07-15 | |
| 2021-02-28 | $21.98K 10-Q · filed 2021-04-14 | |
| 2020-11-30 | $32.75K 10-Q · filed 2021-01-14 | |
| 2020-08-31 | $43.95K 10-K · filed 2020-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |